Parenteral Drugs (India) reports consolidated net loss of Rs 26.86 crore in the September 2018 quarter
Sales decline 87.92% to Rs 8.89 crore
Net Loss of Parenteral Drugs (India) reported to Rs 26.86 crore in the quarter ended September 2018 as against net loss of Rs 29.65 crore during the previous quarter ended September 2017. Sales declined 87.92% to Rs 8.89 crore in the quarter ended September 2018 as against Rs 73.59 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales8.8973.59 -88 OPM %-43.19-6.36 -PBDT-27.69-29.71 7 PBT-32.33-35.74 10 NP-26.86-29.65 9Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2018 | 4:34 PM IST